Drug samples: FDA issues policy on distribution amid COVID-19

The US Food and Drug Administration (FDA) on Monday issued an immediately effective guidance explaining the agency’s enforcement of drug sample distribution requirements during the coronavirus disease (COVID-19) public health emergency.